Grown Rogue International Inc. Stock OTC Markets
Stocks
GRUSF
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Delayed
OTC Markets
10:45:59 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 0.4250 USD | +5.64% |
|
+0.95% | -17.62% |
| Market Cap | 98.93M 87.02M 82.03M 74.84M 140M 9.5B 141M 984M 381M 4.83B 371M 363M 15.73B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 114M 100M 94.72M 86.42M 162M 10.97B 163M 1.14B 440M 5.58B 429M 420M 18.16B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUSF | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript: Grown Rogue International Inc.
| 1 day | +5.64% | ||
| 1 week | +0.95% | ||
| Current month | -6.63% | ||
| 1 month | -9.59% | ||
| 3 months | +0.47% | ||
| 6 months | +37.10% | ||
| Current year | -17.62% |
| 1 week | 0.39 |  | 0.44 |
| 1 month | 0.39 | | 0.47 |
| Current year | 0.27 | | 0.52 |
| 1 year | 0.27 | | 0.52 |
| 3 years | 0.2 | | 0.9 |
| 5 years | 0.02 | | 0.9 |
| 10 years | 0 | | 0.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 2018-11-14 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 2016-09-30 |
| Director of Finance/CFO | 42 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 2018-11-14 |
J. Strickler
CHM | Chairman | 45 | - |
Ryan Kee
BRD | Director/Board Member | 42 | 2024-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.64% | +0.95% | - | - | 98.93M | |
| -2.90% | -2.96% | -13.56% | -6.12% | 13.25B | |
| -1.14% | +0.52% | -32.19% | -56.47% | 4.77B | |
| -1.95% | -0.92% | -6.13% | -7.06% | 4.29B | |
| -2.07% | +0.13% | -5.79% | -33.83% | 3.77B | |
| -0.73% | +3.20% | -22.07% | +4.65% | 3.49B | |
| -0.65% | -2.94% | -3.44% | -5.46% | 3.35B | |
| -1.51% | -1.87% | -14.34% | +0.81% | 3.04B | |
| -1.09% | -0.68% | -22.02% | -18.56% | 2.24B | |
| -0.87% | +0.57% | -26.81% | -22.54% | 1.64B | |
| Average | -0.73% | -0.56% | -16.26% | -16.07% | 4.43B | |
| Weighted average by Cap. | -1.82% | -0.97% | -15.23% | -14.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.76M 22.4M 20.44M 38.22M 2.59B 38.52M 269M 104M 1.32B 101M 99.24M 4.3B | 32.43M 28.52M 26.89M 24.53M 45.88M 3.11B 46.24M 323M 125M 1.58B 122M 119M 5.16B |
| Net income | -11.3M -9.94M -9.37M -8.55M -15.99M -1.09B -16.12M -112M -43.59M -552M -42.44M -41.52M -1.8B | 1.73M 1.52M 1.43M 1.31M 2.45M 166M 2.47M 17.21M 6.67M 84.51M 6.49M 6.35M 275M |
| Net Debt | 3.7M 3.26M 3.07M 2.8M 5.24M 356M 5.28M 36.86M 14.28M 181M 13.91M 13.61M 589M | 15.3M 13.46M 12.69M 11.57M 21.65M 1.47B 21.81M 152M 58.99M 747M 57.44M 56.2M 2.43B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-25 | US$0.4250 | +5.64% | 157,340 |
| 26-09-24 | US$0.4023 | -5.34% | 159,976 |
| 26-09-23 | US$0.4250 | -2.86% | 3,710 |
| 26-09-22 | US$0.4375 | +4.17% | 7,418 |
| 26-09-21 | US$0.4200 | -0.24% | 47,038 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
- GRUSF Stock
Select your edition
All financial news and data tailored to specific country editions
